Vascular brachytherapy after percutaneous transluminal angioplasty of superficial femoral arteries—Polish pilot group

Purpose: The article presents the results of treatment with vascular brachytherapy (VBT) in superficial femoral arteries. This method aims to minimize frequency of restenosis after percutaneous transluminal angioplasty (PTA). Method: Treatment was carried out in 20 cases. The patients with severe st...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cardiovascular radiation medicine 2002-01, Vol.3 (1), p.2-6
Hauptverfasser: Walichiewicz, Piotr, Piecuch, Jerzy, Bia l ̶ as, Brygida, Orkisz, Witold, Fija l ̶ kowski, Marek, Miszczyk, Leszek
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6
container_issue 1
container_start_page 2
container_title Cardiovascular radiation medicine
container_volume 3
creator Walichiewicz, Piotr
Piecuch, Jerzy
Bia l ̶ as, Brygida
Orkisz, Witold
Fija l ̶ kowski, Marek
Miszczyk, Leszek
description Purpose: The article presents the results of treatment with vascular brachytherapy (VBT) in superficial femoral arteries. This method aims to minimize frequency of restenosis after percutaneous transluminal angioplasty (PTA). Method: Treatment was carried out in 20 cases. The patients with severe stenoses or total occlusions verified in angiography were selected. In the group of 19 patients, two were women (the average age of the patients was 58.7 years). VBT was performed immediately after PTA. A 15-Gy dose, with high dose rate, was applied. The dose was calculated based on individually chosen distance from the internal surface of the artery wall, which varied from 2 to 3 mm. The mean observation time after treatment was 8 months. The shortest time was 1 month and the longest 14 months. At the end of the observation time, the control DSA angiography was performed on every patient. Results: During the first 2 months, in three cases, an acute thrombosis in treated artery was observed. In the third month, one treated artery occluded. In the sixth month of observation, one case of acute thrombosis was observed. The rest of the patients were free of restenoses. Conclusions: (1) In superficial femoral arteries, a low value of ankle brachial pressure index (ABPI; below 0.4) is very probably responsible for acute thrombosis after PTA with or without stent implantation followed by VBT. (2) Diabetes, rest ischaemia before treatment, poor vessel status confirmed in angiography may also be responsible for acute thrombosis after VBT. (3) Anticoagulants or antiplatelet (ticlipidine) treatment must be ordered for 6 months after VBT in patients with implanted stents.
doi_str_mv 10.1016/S1522-1865(02)00148-8
format Article
fullrecord <record><control><sourceid>elsevier_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_20650533</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1522186502001488</els_id><sourcerecordid>S1522186502001488</sourcerecordid><originalsourceid>FETCH-LOGICAL-c306t-452e15eea709d8418dc229b54d2cf01e3eb472319978ff4812ed60ac4020d76c3</originalsourceid><addsrcrecordid>eNqFkEtOwzAQhr0A0VI4AsgSG1gEbOflrBCqeEmVQOKxtVxn3BqlcWQ7oOw4BCfkJCRtBUtWI3m-f2b8IXREyTklNLt4oiljEeVZekrYGSE04RHfQePf5xHa9_6tb2RFnO-hEWVJXhSEj9HHq_SqraTDcyfVsgtLcLLpsNQBHG7AqTbIGmzrcXCy9lW7MrWssKwXxjaV9KHDVmPf9qg2yvQtDSvrBsT1Iwz478-vR1sZv8SNqWzAC2fb5gDtall5ONzWCXq5uX6e3kWzh9v76dUsUjHJQpSkDGgKIHNSlDyhvFSMFfM0KZnShEIM8yRnMS2KnGudcMqgzIhUCWGkzDMVT9DJZq71wQivTAC1VLauQQXBSJaSNI57Kt1QylnvHWjROLOSrhOUiEGxWCsWg0tBmFgrFrzPHW9yTTtfQfmX2vrtgcsNAP0f3w244QSoFZTGDReU1vyz4gfBcpFR</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Vascular brachytherapy after percutaneous transluminal angioplasty of superficial femoral arteries—Polish pilot group</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Walichiewicz, Piotr ; Piecuch, Jerzy ; Bia l ̶ as, Brygida ; Orkisz, Witold ; Fija l ̶ kowski, Marek ; Miszczyk, Leszek</creator><creatorcontrib>Walichiewicz, Piotr ; Piecuch, Jerzy ; Bia l ̶ as, Brygida ; Orkisz, Witold ; Fija l ̶ kowski, Marek ; Miszczyk, Leszek</creatorcontrib><description>Purpose: The article presents the results of treatment with vascular brachytherapy (VBT) in superficial femoral arteries. This method aims to minimize frequency of restenosis after percutaneous transluminal angioplasty (PTA). Method: Treatment was carried out in 20 cases. The patients with severe stenoses or total occlusions verified in angiography were selected. In the group of 19 patients, two were women (the average age of the patients was 58.7 years). VBT was performed immediately after PTA. A 15-Gy dose, with high dose rate, was applied. The dose was calculated based on individually chosen distance from the internal surface of the artery wall, which varied from 2 to 3 mm. The mean observation time after treatment was 8 months. The shortest time was 1 month and the longest 14 months. At the end of the observation time, the control DSA angiography was performed on every patient. Results: During the first 2 months, in three cases, an acute thrombosis in treated artery was observed. In the third month, one treated artery occluded. In the sixth month of observation, one case of acute thrombosis was observed. The rest of the patients were free of restenoses. Conclusions: (1) In superficial femoral arteries, a low value of ankle brachial pressure index (ABPI; below 0.4) is very probably responsible for acute thrombosis after PTA with or without stent implantation followed by VBT. (2) Diabetes, rest ischaemia before treatment, poor vessel status confirmed in angiography may also be responsible for acute thrombosis after VBT. (3) Anticoagulants or antiplatelet (ticlipidine) treatment must be ordered for 6 months after VBT in patients with implanted stents.</description><identifier>ISSN: 1522-1865</identifier><identifier>DOI: 10.1016/S1522-1865(02)00148-8</identifier><identifier>PMID: 12479908</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute thrombosis ; Aged ; Angioplasty, Balloon ; ANTICOAGULANTS ; Arterial Occlusive Diseases - complications ; Arterial Occlusive Diseases - epidemiology ; Arterial Occlusive Diseases - therapy ; ARTERIES ; BIOMEDICAL RADIOGRAPHY ; Blood Vessel Prosthesis Implantation ; BRACHYTHERAPY ; DOSE RATES ; Dose-Response Relationship, Radiation ; Female ; Femoral arteries ; Femoral Artery - diagnostic imaging ; Femoral Artery - surgery ; Gamma Rays - therapeutic use ; Graft Occlusion, Vascular - epidemiology ; Graft Occlusion, Vascular - etiology ; Graft Occlusion, Vascular - therapy ; Humans ; Male ; Middle Aged ; PATIENTS ; Pilot Projects ; Poland ; Radiography ; RADIOLOGY AND NUCLEAR MEDICINE ; Reoperation ; Restenosis ; Risk Factors ; Stents ; THROMBOSIS ; Thrombosis - epidemiology ; Thrombosis - etiology ; Thrombosis - therapy ; Tibial Arteries - diagnostic imaging ; Tibial Arteries - surgery ; Treatment Outcome ; Vascular brachytherapy</subject><ispartof>Cardiovascular radiation medicine, 2002-01, Vol.3 (1), p.2-6</ispartof><rights>2002 Elsevier Science Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c306t-452e15eea709d8418dc229b54d2cf01e3eb472319978ff4812ed60ac4020d76c3</citedby><cites>FETCH-LOGICAL-c306t-452e15eea709d8418dc229b54d2cf01e3eb472319978ff4812ed60ac4020d76c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12479908$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/20650533$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Walichiewicz, Piotr</creatorcontrib><creatorcontrib>Piecuch, Jerzy</creatorcontrib><creatorcontrib>Bia l ̶ as, Brygida</creatorcontrib><creatorcontrib>Orkisz, Witold</creatorcontrib><creatorcontrib>Fija l ̶ kowski, Marek</creatorcontrib><creatorcontrib>Miszczyk, Leszek</creatorcontrib><title>Vascular brachytherapy after percutaneous transluminal angioplasty of superficial femoral arteries—Polish pilot group</title><title>Cardiovascular radiation medicine</title><addtitle>Cardiovasc Radiat Med</addtitle><description>Purpose: The article presents the results of treatment with vascular brachytherapy (VBT) in superficial femoral arteries. This method aims to minimize frequency of restenosis after percutaneous transluminal angioplasty (PTA). Method: Treatment was carried out in 20 cases. The patients with severe stenoses or total occlusions verified in angiography were selected. In the group of 19 patients, two were women (the average age of the patients was 58.7 years). VBT was performed immediately after PTA. A 15-Gy dose, with high dose rate, was applied. The dose was calculated based on individually chosen distance from the internal surface of the artery wall, which varied from 2 to 3 mm. The mean observation time after treatment was 8 months. The shortest time was 1 month and the longest 14 months. At the end of the observation time, the control DSA angiography was performed on every patient. Results: During the first 2 months, in three cases, an acute thrombosis in treated artery was observed. In the third month, one treated artery occluded. In the sixth month of observation, one case of acute thrombosis was observed. The rest of the patients were free of restenoses. Conclusions: (1) In superficial femoral arteries, a low value of ankle brachial pressure index (ABPI; below 0.4) is very probably responsible for acute thrombosis after PTA with or without stent implantation followed by VBT. (2) Diabetes, rest ischaemia before treatment, poor vessel status confirmed in angiography may also be responsible for acute thrombosis after VBT. (3) Anticoagulants or antiplatelet (ticlipidine) treatment must be ordered for 6 months after VBT in patients with implanted stents.</description><subject>Acute thrombosis</subject><subject>Aged</subject><subject>Angioplasty, Balloon</subject><subject>ANTICOAGULANTS</subject><subject>Arterial Occlusive Diseases - complications</subject><subject>Arterial Occlusive Diseases - epidemiology</subject><subject>Arterial Occlusive Diseases - therapy</subject><subject>ARTERIES</subject><subject>BIOMEDICAL RADIOGRAPHY</subject><subject>Blood Vessel Prosthesis Implantation</subject><subject>BRACHYTHERAPY</subject><subject>DOSE RATES</subject><subject>Dose-Response Relationship, Radiation</subject><subject>Female</subject><subject>Femoral arteries</subject><subject>Femoral Artery - diagnostic imaging</subject><subject>Femoral Artery - surgery</subject><subject>Gamma Rays - therapeutic use</subject><subject>Graft Occlusion, Vascular - epidemiology</subject><subject>Graft Occlusion, Vascular - etiology</subject><subject>Graft Occlusion, Vascular - therapy</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>PATIENTS</subject><subject>Pilot Projects</subject><subject>Poland</subject><subject>Radiography</subject><subject>RADIOLOGY AND NUCLEAR MEDICINE</subject><subject>Reoperation</subject><subject>Restenosis</subject><subject>Risk Factors</subject><subject>Stents</subject><subject>THROMBOSIS</subject><subject>Thrombosis - epidemiology</subject><subject>Thrombosis - etiology</subject><subject>Thrombosis - therapy</subject><subject>Tibial Arteries - diagnostic imaging</subject><subject>Tibial Arteries - surgery</subject><subject>Treatment Outcome</subject><subject>Vascular brachytherapy</subject><issn>1522-1865</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtOwzAQhr0A0VI4AsgSG1gEbOflrBCqeEmVQOKxtVxn3BqlcWQ7oOw4BCfkJCRtBUtWI3m-f2b8IXREyTklNLt4oiljEeVZekrYGSE04RHfQePf5xHa9_6tb2RFnO-hEWVJXhSEj9HHq_SqraTDcyfVsgtLcLLpsNQBHG7AqTbIGmzrcXCy9lW7MrWssKwXxjaV9KHDVmPf9qg2yvQtDSvrBsT1Iwz478-vR1sZv8SNqWzAC2fb5gDtall5ONzWCXq5uX6e3kWzh9v76dUsUjHJQpSkDGgKIHNSlDyhvFSMFfM0KZnShEIM8yRnMS2KnGudcMqgzIhUCWGkzDMVT9DJZq71wQivTAC1VLauQQXBSJaSNI57Kt1QylnvHWjROLOSrhOUiEGxWCsWg0tBmFgrFrzPHW9yTTtfQfmX2vrtgcsNAP0f3w244QSoFZTGDReU1vyz4gfBcpFR</recordid><startdate>200201</startdate><enddate>200201</enddate><creator>Walichiewicz, Piotr</creator><creator>Piecuch, Jerzy</creator><creator>Bia l ̶ as, Brygida</creator><creator>Orkisz, Witold</creator><creator>Fija l ̶ kowski, Marek</creator><creator>Miszczyk, Leszek</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>OTOTI</scope></search><sort><creationdate>200201</creationdate><title>Vascular brachytherapy after percutaneous transluminal angioplasty of superficial femoral arteries—Polish pilot group</title><author>Walichiewicz, Piotr ; Piecuch, Jerzy ; Bia l ̶ as, Brygida ; Orkisz, Witold ; Fija l ̶ kowski, Marek ; Miszczyk, Leszek</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c306t-452e15eea709d8418dc229b54d2cf01e3eb472319978ff4812ed60ac4020d76c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Acute thrombosis</topic><topic>Aged</topic><topic>Angioplasty, Balloon</topic><topic>ANTICOAGULANTS</topic><topic>Arterial Occlusive Diseases - complications</topic><topic>Arterial Occlusive Diseases - epidemiology</topic><topic>Arterial Occlusive Diseases - therapy</topic><topic>ARTERIES</topic><topic>BIOMEDICAL RADIOGRAPHY</topic><topic>Blood Vessel Prosthesis Implantation</topic><topic>BRACHYTHERAPY</topic><topic>DOSE RATES</topic><topic>Dose-Response Relationship, Radiation</topic><topic>Female</topic><topic>Femoral arteries</topic><topic>Femoral Artery - diagnostic imaging</topic><topic>Femoral Artery - surgery</topic><topic>Gamma Rays - therapeutic use</topic><topic>Graft Occlusion, Vascular - epidemiology</topic><topic>Graft Occlusion, Vascular - etiology</topic><topic>Graft Occlusion, Vascular - therapy</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>PATIENTS</topic><topic>Pilot Projects</topic><topic>Poland</topic><topic>Radiography</topic><topic>RADIOLOGY AND NUCLEAR MEDICINE</topic><topic>Reoperation</topic><topic>Restenosis</topic><topic>Risk Factors</topic><topic>Stents</topic><topic>THROMBOSIS</topic><topic>Thrombosis - epidemiology</topic><topic>Thrombosis - etiology</topic><topic>Thrombosis - therapy</topic><topic>Tibial Arteries - diagnostic imaging</topic><topic>Tibial Arteries - surgery</topic><topic>Treatment Outcome</topic><topic>Vascular brachytherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Walichiewicz, Piotr</creatorcontrib><creatorcontrib>Piecuch, Jerzy</creatorcontrib><creatorcontrib>Bia l ̶ as, Brygida</creatorcontrib><creatorcontrib>Orkisz, Witold</creatorcontrib><creatorcontrib>Fija l ̶ kowski, Marek</creatorcontrib><creatorcontrib>Miszczyk, Leszek</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>OSTI.GOV</collection><jtitle>Cardiovascular radiation medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Walichiewicz, Piotr</au><au>Piecuch, Jerzy</au><au>Bia l ̶ as, Brygida</au><au>Orkisz, Witold</au><au>Fija l ̶ kowski, Marek</au><au>Miszczyk, Leszek</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vascular brachytherapy after percutaneous transluminal angioplasty of superficial femoral arteries—Polish pilot group</atitle><jtitle>Cardiovascular radiation medicine</jtitle><addtitle>Cardiovasc Radiat Med</addtitle><date>2002-01</date><risdate>2002</risdate><volume>3</volume><issue>1</issue><spage>2</spage><epage>6</epage><pages>2-6</pages><issn>1522-1865</issn><abstract>Purpose: The article presents the results of treatment with vascular brachytherapy (VBT) in superficial femoral arteries. This method aims to minimize frequency of restenosis after percutaneous transluminal angioplasty (PTA). Method: Treatment was carried out in 20 cases. The patients with severe stenoses or total occlusions verified in angiography were selected. In the group of 19 patients, two were women (the average age of the patients was 58.7 years). VBT was performed immediately after PTA. A 15-Gy dose, with high dose rate, was applied. The dose was calculated based on individually chosen distance from the internal surface of the artery wall, which varied from 2 to 3 mm. The mean observation time after treatment was 8 months. The shortest time was 1 month and the longest 14 months. At the end of the observation time, the control DSA angiography was performed on every patient. Results: During the first 2 months, in three cases, an acute thrombosis in treated artery was observed. In the third month, one treated artery occluded. In the sixth month of observation, one case of acute thrombosis was observed. The rest of the patients were free of restenoses. Conclusions: (1) In superficial femoral arteries, a low value of ankle brachial pressure index (ABPI; below 0.4) is very probably responsible for acute thrombosis after PTA with or without stent implantation followed by VBT. (2) Diabetes, rest ischaemia before treatment, poor vessel status confirmed in angiography may also be responsible for acute thrombosis after VBT. (3) Anticoagulants or antiplatelet (ticlipidine) treatment must be ordered for 6 months after VBT in patients with implanted stents.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>12479908</pmid><doi>10.1016/S1522-1865(02)00148-8</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1522-1865
ispartof Cardiovascular radiation medicine, 2002-01, Vol.3 (1), p.2-6
issn 1522-1865
language eng
recordid cdi_osti_scitechconnect_20650533
source MEDLINE; Alma/SFX Local Collection
subjects Acute thrombosis
Aged
Angioplasty, Balloon
ANTICOAGULANTS
Arterial Occlusive Diseases - complications
Arterial Occlusive Diseases - epidemiology
Arterial Occlusive Diseases - therapy
ARTERIES
BIOMEDICAL RADIOGRAPHY
Blood Vessel Prosthesis Implantation
BRACHYTHERAPY
DOSE RATES
Dose-Response Relationship, Radiation
Female
Femoral arteries
Femoral Artery - diagnostic imaging
Femoral Artery - surgery
Gamma Rays - therapeutic use
Graft Occlusion, Vascular - epidemiology
Graft Occlusion, Vascular - etiology
Graft Occlusion, Vascular - therapy
Humans
Male
Middle Aged
PATIENTS
Pilot Projects
Poland
Radiography
RADIOLOGY AND NUCLEAR MEDICINE
Reoperation
Restenosis
Risk Factors
Stents
THROMBOSIS
Thrombosis - epidemiology
Thrombosis - etiology
Thrombosis - therapy
Tibial Arteries - diagnostic imaging
Tibial Arteries - surgery
Treatment Outcome
Vascular brachytherapy
title Vascular brachytherapy after percutaneous transluminal angioplasty of superficial femoral arteries—Polish pilot group
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T17%3A00%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vascular%20brachytherapy%20after%20percutaneous%20transluminal%20angioplasty%20of%20superficial%20femoral%20arteries%E2%80%94Polish%20pilot%20group&rft.jtitle=Cardiovascular%20radiation%20medicine&rft.au=Walichiewicz,%20Piotr&rft.date=2002-01&rft.volume=3&rft.issue=1&rft.spage=2&rft.epage=6&rft.pages=2-6&rft.issn=1522-1865&rft_id=info:doi/10.1016/S1522-1865(02)00148-8&rft_dat=%3Celsevier_osti_%3ES1522186502001488%3C/elsevier_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/12479908&rft_els_id=S1522186502001488&rfr_iscdi=true